Podcasts about fta

Send a textThis week the Madcaps were joined by Bri, the Community Engagement Manager for the Florida Trail Association as we discuss the details of the 2nd annual Florida Trail Fest.  This year, the FTA staff has been hard at work making the trail fest significantly larger and more engaging than last year.  For the Florida Trail Fest schedule and details, click hereVendors scheduled to attend the Trailfest are:ZPacks Florida State Parks Foundation Pinhoti Outdoor Center Hangcon/Hammock Hangers PodcastCover Yer Assets REI Co-opDottie Foods University of Florida REC LabWildBatch Authentica Travel ALDHAPatchoulize Monster KrunchTrekallaAmerican Red CrossBend There Done ThatCracker Trail Co.Terpstra GlassFlorida Fish and Wildlife Conservation CommissionBead by Bead AdventuresOgZ DeZignsSponsors of Trail Fest are:ZPacksFlorida HikesFlorida Wildlife CorridorCS Instant CoffeeIn The Hedges Hiker MinistryFT Thru HikesSuwannee Hardware StoreSandhill Chapter FTAFarOutNoNormalFood Trucks attending:Wild Man FoodsHibachi HotspotRadha's KitchenRaffle Donations are:InkkasZenbivyKula ClothSWOOPIn The Hedges Hiker MinistryFarOutOutdoor Adventure TrainingREI Co-opPlease subscribe! Shares and reviews are much appreciated!Get your FREE sticker from the Florida Springs Council and sign up to be a springs advocate at https://www.floridaspringscouncil.org/madcapsQuestions and comments can be emailed at thefloridamadcaps@gmail.comRyan can be found on Instagram at: https://www.instagram.com/the_fl_excursionist/Chris and Chelsey can be found at https://www.instagram.com/sunshinestateseekers/?hl=en

韓國舔中舔到自己快要金融風暴了？ 沒錯！韓國跌倒了，台灣要吃飽啦！ 李在明加速親中，嗆美軍事行動，這是完全搞不清楚狀況，台灣的機會來了！ 中韓FTA簽署後，韓國對中國的貿易優勢竟逐步被侵蝕，從順差走向逆差，多項產業出現結構性警訊，真相為何？ 美國最高法院裁定川普對等關稅無效，也讓全球供應鏈與台韓競爭格局出現新變數。 帶你用數據看懂：為何韓國股市大漲韓元卻重貶？什麼產業成為韓國最後浮木？為何韓國應該跟台美說說謝謝？最後最重要的，台灣產業的關鍵機會在哪裡！ 分享精彩的一集給你的親友吧！ 全台獨家的世界經濟追劇深入報導，精彩萬分，持續連載中！ （現在就加入會員支持我們，還可以看到更多專屬影片～） https://www.youtube.com/@emmytw/join 新年賀歲企業甄嬛傳

Anti-immigration political parties have been boosted in many countries. Now NZ First forcing the issue onto the news agenda. Also: is streaming eating itself? And why did one friendly umbrella gesture end up heavily analysed in our media? Read more about this episode of Mediawatch on the RNZ websiteLearn more: Mediawatch: Immigration amping up in election year | RNZ NewsIn this episode:0:55 Immigration as a political wedge issue around the world4:55 NZ First puts immigration on the agenda over its objections to an FTA with India - giving the media a headache with the prospect of more to come.19:45 HBO leaves Sky TV to launch its own HBO Max subscription service here. Are we already over-subscribed?22:56 Tech writer Peter Griffin on streaming hitting the ceiling worldwide - and what it might mean for Sky TV (without HBO)Guests: Peter Griffin, BusinessDeskFollow Mediawatch and listen on Apple Podcasts, Spotify or any podcast app to make sure you never miss an episode.Find more RNZ Podcasts at the new section of the RNZ website at rnz.co.nz/podcastsGo to this episode on rnz.co.nz for more details

As I watch Chris Hipkins, presumably gleefully, mess about with the India Free Trade deal, I'm reminded this is not the Labour Party that did the FTA with China. Hipkins is no Helen Clark and in that is a great sadness. For all those who occasionally contact me and ask of the possibility of a so-called “grand coalition” —a relationship between the Labour and National parties— before you ask, next time look at the way Hipkins plays these games and there is your answer. Even in areas of broad agreement, they still can't act like grownups. It's also a lesson in name vs substance. The Labour Party of the past few years is nothing like Labour of the late 90's and early 2000's. That was a centrist version. Yes, they still handed out free money to people like students to bribe them in election year. But the rest of the time they actually ran the economy in growth. Compared to Barbara Edmonds, Michael Cullen was a conservative. In the early parts of 1984 Labour, with David Lange, was similar, and here is your irony that Hipkins fails to recognise: when Labour are, broadly speaking, middle of the road they are actually popular. Ask Bob Hawke or Paul Keating or Tony Blair – centrist Labour is successful Labour. By the time you take modern Labour with Hipkins and Sepuloni, and add the Greens in the mix, you are seeing the left wing “group think” that not only keeps them out of office, but leads to the sort of game playing we have with an FTA. Yes, the Government probably shouldn't have to rely on them and for all the games Labour plays, New Zealand First is just as bad with their xenophobic nonsense. But Labour once had a global view. It's not like the Chinese weren't thought of with great suspicion prior to 2008. But the bigger picture was at play. The realisation that large countries and their economies could be good for everyone was a driving force. What Labour would do well to do is put this country first. Not score points, not look like children, and not pretend they actually had anything to do with negotiating this thing at all. FTAs are big picture, not a three-year electoral cycle game. I don't think I'm alone in wishing there were more adults in the room. Labour 1999-2008 put the current lot to shame. See omnystudio.com/listener for privacy information.

Former Dutchess executive leaves FTA job after six months Marc Molinaro, the former Dutchess County executive and U.S. congressman, will resign as administrator of the Federal Transit Administration on Friday (Feb. 20) to return to New York. He held the job for six months. According to Politico and the Times Union, each citing an anonymous source, Molinaro plans to campaign for a state Assembly seat being vacated by Chris Tague, who is running for the state Senate. The seat represents District 102, which covers Greene and Schoharie counties in the Catskills. In a post on X, Molinaro wrote, "I'm coming home to be closer to my family and get back into the fight." Before becoming Dutchess County executive in 2011, Molinaro served five years as a county legislator and two terms in the state Assembly. He was also the Republican candidate for governor in 2018. He was elected to the House in 2023 but lost his bid for re-election to Josh Riley. Before joining the FTA, Molinaro had been a senior advisor to Transportation Secretary Sean Duffy.

Labour's issued a list of demands for the Government before it will sign up to the Free Trade Agreement with India. Chris Hipkins says the FTA needs stronger safeguards against exploiting migrants. He wants the full official advice on the deal released to Labour. He says the Party's particularly concerned around the expectation Kiwi businesses will invest $33 billion in India over 15 years. "I think it's almost entirely impossible, and that's why I'm surprised that they're trying to sign us up to that. To put that into context, I think that over the last 25 years, less than $1 billion NZD has been invested in India." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Labour has raised some concerns over the FTA with India, but Finance Minister Nicola Willis is pushing back. The opposition says they want the un-redacted advice about the deal and greater protection for migrant workers. Nicola Willis says there's strong aspirations in the agreement to promote investment. "What it's saying is - let's both agree to promote significant levels of investment in our respective countries, let's put some aspirational targets out there." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Tonight on The Huddle, Trish Sherson from Sherson Willis PR and broadcaster Mark Sainsbury joined in on a discussion about the following issues of the day - and more! New Zealand is set to host its first State of Origin match at Eden Park next year. Do we think this is good news? What does this development mean for Auckland? The FTA with India has sparked debate and discussion, with Labour outlining their concerns. What do we make of this? What do we think really defines 'Kiwi cuisine'? LISTEN ABOVESee omnystudio.com/listener for privacy information.

Labour has raised some concerns over the FTA with India, but Finance Minister Nicola Willis is pushing back. The opposition says they want the un-redacted advice about the deal and greater protection for migrant workers. Nicola Willis says there's strong aspirations in the agreement to promote investment. "What it's saying is - let's both agree to promote significant levels of investment in our respective countries, let's put some aspirational targets out there." LISTEN ABOVESee omnystudio.com/listener for privacy information.

On the Early Edition with Ryan Bridge Full Show Podcast Monday 16th of Feburary 2025, The Government's allowing Eden Park to host 22 concerts a year, on any day, without the need for resource consent, Heart of the City CEO Viv Beck shares her thoughts. Labour's laying down conditions on the FTA with India, Beef and Lamb Chair Kate Acland tells Ryan what it will take to get the deal across the line. Andrew Alderson has the latest on the weekend's sport. Plus, UK/Europe Correspondent Gavin Grey has the latest on the UK and Europe accusing the Kremlin of assassinating Russian opposition leader Alexei Navalny and a water leak at the Louvre that caused damage to 19th century painting. Get the Early Edition Full Show Podcast every weekday on iHeartRadio, or wherever you get your podcasts. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Labour is hesitant to put their support behind an India FTA without the government meeting certain conditions. It says free trade is a net positive, but agreements shouldn't cause harm to New Zealand - which is what we risk with this FTA. LISTEN ABOVESee omnystudio.com/listener for privacy information.

India's new trade pacts with the EU and US, and the big question: Will Delhi revisit its decision to abandon RCEP? Synopsis: The Straits Times’ senior columnist Ravi Velloor distils 45 years of experience covering the Asian continent, with expert guests. A flurry of trade agreements announced by India – first, a “mother of all trade deals” FTA with the European Union, and days later, a framework deal with the US that saw Washington slashing its punitive tariffs on Indian exports to levels just below that of Vietnam and Malaysia, involves wider strategic calculations on every side. In this wide-ranging conversation, host Ravi Velloor speaks with Ambassador Jawed Ashraf, Chairman of India Trade Promotion Organisation and former foreign policy aide to Prime Minister Narendra Modi. Having served as envoy to Singapore and France, he weighs in on the thinking behind the deals, India’s newfound confidence to sign on to market-opening agreements, and the chances of India revisiting its decision to abandon the Asean-backed RCEP, or Regional Comprehensive Economic Partnership. They both discuss India’s trade imperatives, the tighter embrace by India of the European Union which is itself adjusting to a multipolar world, and how quality trade agreements help set the stage for foreign direct investment flows and stronger strategic ties. They also chat about the calibrated opening that India is making with China, even as it is not yet ready to revisit entering RCEP. Highlights (click/tap above) 1:08 India withdrawal from RCEP and focus on bilateral relations 5:15 A greater alignment of trade with geopolitics 8:46 Roots of India’s “self-confidence” to sign trade deals 11:07 What the trade deals mean for ordinary Indians 14:11 EU looks to India, Taiwan in the AI age 18:14 EU-India, and a message to the US 20:53 Did Trump negotiate with a “gun to India’s head”? 24:18 Why stress on defence in US-India trade deal 27:01 RCEP: A calibrated opening is ongoing with China Read Ravi's columns: https://str.sg/3xRP Follow Ravi on X: https://twitter.com/RaviVelloor Sign up for ST’s weekly Asian Insider newsletter: https://str.sg/sfpz Host: Ravi Velloor (velloor@sph.com.sg) Produced and edited by: Fa’izah Sani Executive producer: Ernest Luis Follow Asian Insider Podcast on Fridays here: Channel: https://str.sg/JWa7 Apple Podcasts: https://str.sg/JWa8 Spotify: https://str.sg/JWaX Feedback to: podcast@sph.com.sg SPH Awedio app: https://www.awedio.sg --- Follow more ST podcast channels: All-in-one ST Podcasts channel: https://str.sg/wvz7 Get more updates: http://str.sg/stpodcasts The Usual Place Podcast YouTube: https://str.sg/4Vwsa --- Get The Straits Times app, which has a dedicated podcast player section: The App Store: https://str.sg/icyB Google Play: https://str.sg/icyX --- #STAsianInsiderSee omnystudio.com/listener for privacy information.

India's new trade pacts with the EU and US, and the big question: Will Delhi revisit its decision to abandon RCEP? Synopsis: The Straits Times’ senior columnist Ravi Velloor distils 45 years of experience covering the Asian continent, with expert guests. A flurry of trade agreements announced by India – first, a “mother of all trade deals” FTA with the European Union, and days later, a framework deal with the US that saw Washington slashing its punitive tariffs on Indian exports to levels just below that of Vietnam and Malaysia, involves wider strategic calculations on every side. In this wide-ranging conversation, host Ravi Velloor speaks with Ambassador Jawed Ashraf, Chairman of India Trade Promotion Organisation and former foreign policy aide to Prime Minister Narendra Modi. Having served as envoy to Singapore and France, he weighs in on the thinking behind the deals, India’s newfound confidence to sign on to market-opening agreements, and the chances of India revisiting its decision to abandon the Asean-backed RCEP, or Regional Comprehensive Economic Partnership. They both discuss India’s trade imperatives, the tighter embrace by India of the European Union which is itself adjusting to a multipolar world, and how quality trade agreements help set the stage for foreign direct investment flows and stronger strategic ties. They also chat about the calibrated opening that India is making with China, even as it is not yet ready to revisit entering RCEP. Highlights (click/tap above) 1:08 India withdrawal from RCEP and focus on bilateral relations 5:15 A greater alignment of trade with geopolitics 8:46 Roots of India’s “self-confidence” to sign trade deals 11:07 What the trade deals mean for ordinary Indians 14:11 EU looks to India, Taiwan in the AI age 18:14 EU-India, and a message to the US 20:53 Did Trump negotiate with a “gun to India’s head”? 24:18 Why stress on defence in US-India trade deal 27:01 RCEP: A calibrated opening is ongoing with China Read Ravi's columns: https://str.sg/3xRP Follow Ravi on X: https://twitter.com/RaviVelloor Sign up for ST’s weekly Asian Insider newsletter: https://str.sg/sfpz Host: Ravi Velloor (velloor@sph.com.sg) Produced and edited by: Fa’izah Sani Executive producer: Ernest Luis Follow Asian Insider Podcast on Fridays here: Channel: https://str.sg/JWa7 Apple Podcasts: https://str.sg/JWa8 Spotify: https://str.sg/JWaX Feedback to: podcast@sph.com.sg SPH Awedio app: https://www.awedio.sg --- Follow more ST podcast channels: All-in-one ST Podcasts channel: https://str.sg/wvz7 Get more updates: http://str.sg/stpodcasts The Usual Place Podcast YouTube: https://str.sg/4Vwsa --- Get The Straits Times app, which has a dedicated podcast player section: The App Store: https://str.sg/icyB Google Play: https://str.sg/icyX --- #STAsianInsiderSee omnystudio.com/listener for privacy information.

On the Mike Hosking Breakfast Full Show Podcast for Wednesday 11th of February, Trade Minister Todd McClay puts to bed once and for all what rights Indian students will have as part of the FTA. Zoi Sadowski-Synnott discusses the success New Zealand is having at this year's Winter Olympics, and her Big Air silver medal. Mark Mitchell and Ginny Andersen talk the success, or not, of the Retail Advisory Group, the LNG facility and whether it's a fee or levy, and the latest in the House on Politics Wednesday. Get the Mike Hosking Breakfast Full Show Podcast every weekday morning on iHeartRadio, or wherever you get your podcasts. LISTEN ABOVE See omnystudio.com/listener for privacy information.

On the Early Edition with Ryan Bridge Full Show Podcast Wednesday the 11th of Feburary 2025, Todd McClay's confirmed the FTA with india will not allow the Government to cap the number of students coming in from India, Managing Director & Immigration Lawyer at Queen City Law, Marcus Beveridge shares his thoughts. The Retail Crime advisory group is being disbanded in early May, Retail NZ CEO Carolyn Young tells Ryan where it all went wrong. US Critical Materials Executive Chairman Harvey Kaye tells Ryan what a Critical Minerals deal could look like between the US and New Zealand. Plus, UK/Europe Correspondent Mike Pearse has the latest on Keir Starmer refusing to resign and organisers at the Winter Olympics have been forced to apologise to some athletes after their medals broke. Get the Early Edition Full Show Podcast every weekday on iHeartRadio, or wherever you get your podcasts. LISTEN ABOVE See omnystudio.com/listener for privacy information.

It's the debut of R&D with BT! Former Charlotte City Councilmen Tariq Bokhari & Larken Egleston join Bo Thompson & Beth Troutman for a weekly conversation about local, state, and national politics... and whatever else comes up along the way. This week: reaction to the FTA audit of CATS, thoughts on some recent headline-making comments from Senator Thom Tillis, the upcoming NC Senate race to replace him, and more heavyweight concerts announced for Bank of America Stadium.See omnystudio.com/listener for privacy information.

Kumar frames the India–EU FTA as a deal India needed, not one it merely chose, arguing that with the multilateral trade system weakened, FTAs have become the practical route to secure market access and signal openness to investment. He places the EU among India's “$100 billion club” trading partners and explains why this agreement fills a gap India cannot realistically close with China, and cannot replicate with the United States in the form of a full FTA.On timing, he calls the early 2010s a missed opportunity but notes that current geopolitical conditions have raised India's value for Europe, including Europe's push to de-risk from China and the absence of an EU–U.S. FTA. A major thread is regulation: Kumar acknowledges the EU's regulatory intensity, but argues India must adapt to global technical and sanitary standards, using the agreement's timelines and technical assistance to reduce friction and help industry upgrade over time.He clarifies the trade-offs that made the deal viable: core agriculture and dairy are left out due to political sensitivities on both sides; government procurement is excluded due to India's constraints and federal realities; and investment protection and geographical indications are kept on separate tracks to avoid a more complex EU-wide ratification path. He also describes how negotiations manage domestic sensitivities through consultation with industry, transition periods, tariff-rate quotas, and product thresholds, particularly in sectors like autos, aiming to expose firms gradually to competition while pushing manufacturing to become more competitive.In closing, Kumar argues the hard work starts after signing. He stresses that Indian industry must actually use the agreement's tariff concessions, pointing to historically low utilization of FTAs—and that domestic reforms cannot be postponed if India wants the deal to deliver results. He highlights reforms in agriculture, labor implementation, power, and land acquisition, and ties this to a broader shift he sees globally: trade policy and security policy are increasingly moving into alignment, especially in a world of dual-use technology and tighter strategic partnerships.Episode ContributorsDinakar Peri is a fellow in the Security Studies program at Carnegie India.Ambassador Mohan Kumar has an outstanding career in the Indian Foreign Service lasting 36 years which culminated in his being India's Ambassador to France based in Paris. Under his watch, the Indo-French strategic partnership was strengthened and consolidated further in spheres such as defense, space, nuclear & solar energy, smart cities and investment. Earlier, Mohan Kumar was India's Ambassador to the Kingdom of Bahrain where he witnessed and dealt with a strategically complex region characterized by events such as the “Arab Spring”. Every two weeks, Interpreting India brings you diverse voices from India and around the world to explore the critical questions shaping the nation's future. We delve into how technology, the economy, and foreign policy intertwine to influence India's relationship with the global stage.As a Carnegie India production, hosted by Carnegie scholars, Interpreting India, a Carnegie India production, provides insightful perspectives and cutting-edge by tackling the defining questions that chart India's course through the next decade.Stay tuned for thought-provoking discussions, expert insights, and a deeper understanding of India's place in the world.Don't forget to subscribe, share, and leave a review to join the conversation and be part of Interpreting India's journey.

On Episode 789 of The Core Report, financial journalist Govindraj Ethiraj talks to Prasanna Tantri, Associate Professor of Finance and the Executive Director of the Centre for Analytical Finance at the Indian School of Business (ISB) as well as Rajesh Sinha, Independent Director at Sahyadri Farms.SHOW NOTES(00:00) Stories of the Day(00:50) India-US Trade Deal Finalised(02:41) The markets are up again but all eyes on metals(05:23) The gold and silver story(10:47) Oil prices dip after Trump says he will talk to Iran.(11:47) What are the top level Budget numbers looking like?(20:50) India's farmers can seize the FTA opportunity but there is work to do.Register for India Finance and Innovation Forum 2026https://tinyurl.com/IFIFCOREFor more of our coverage check out ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠thecore.in⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Subscribe to our Newsletter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow us on:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Linkedin⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠

Those opposing our FTA with India have got be guilty of economic treason, don't they? We're a small trading nation with lots of food, and world markets who need our red meat and our milk. The closer the country, the better. The higher-value-add, the better. And the sugar on top is tariff-free access, so our competitive advantaged producing the world best dairy and sheep and beef, and Kiwifruit, can all me admired and loved by the word at a reasonable price. When Helen Clark and Phil Goff signed the deal in Beijing back in 2007, two-way trade was $8. It's now $41-billion. It's now our largest trading partner. We are on the cusp of another bonanza just like with a country much bigger and meddle class about the crack on. It's to come the third largest economy in the world. However, some kiwi politicians believe this is somehow a bad thing. That selling our best produces to other countries at cheaper prices, unencumbered another' tax regime, how is that not a good idea? Why because we may have take an 1700 Indians on working visas coming here? So what. They work hard, they hussle. They don't piss around fishing at the beach or sitting on the couch when they should be working. Migrants do the jobs iwi's feel they're too posh to do in society. It's hard work. Honest work. And it needs to be done. Why not let people who want to work, work. And you don't, you don't get anything. Fish till your hearts content. But this country should be filled with ambitious people who want to make the most of it. That's what FTAs do and I can't understand people don't it.See omnystudio.com/listener for privacy information.

The recently concluded Free Trade Agreement, or FTA, between India and the European Union is unprecedented. Few bilateral arrangements in modern trade diplomacy can match the scale or ambition of what the ‘mother of all deals' has unlocked. Established in 1968, the EU Customs Union is a foundational pillar of European economic integration. With Turkey in the mix, India's biggest deal with the EU suddenly looks more complicated. Watch ThePrint Consulting Editor (International & Strategic Affairs) Swasti Rao explains. To read: https://theprint.in/opinion/india-eu-fta-turkey-customs-union/2840686/?amp

Now, listen — I think it's a little early in the year to be making too many predictions about election year. But having said that, I do think there is a very strong chance that Winston Peters might be the story of the year. If he carries on the way he is in the polls, he could well be in the double digits — well into the double digits — by the time November's election rolls around. He's already sitting somewhere between 10 and 12 percent in the past couple of polls, and generally minor parties go up in polling the closer we get to election day because of the extra attention they get during the campaign. Commentators are already talking about the possibility of the next government being just National and New Zealand First — no ACT in there — with the two of them together potentially being enough. That could happen if Winston keeps climbing the way he is, and obviously if National can get its act together and lift its vote share. If you don't believe it's possible that Winston will climb further, just look at what he did this week. He pulled out that classic Winston trick of whipping up the anti‑immigrant rhetoric again. I honestly didn't think there was much of that sentiment around at the moment — until he started talking, and suddenly the texts about immigrants started rolling in. Winston can sniff out an election platform like no one else. He knows there's probably an increased number of people who are gagging for a conspiracy — like “the government is trying to hide the FTA documents they're trying to roll on us". And what we were also reminded of this week is that he's completely unencumbered by the facts. A lot of what he said was just complete nonsense. Here's a question for you: if it does end up being just New Zealand First and National, and Winston is 81 years old, is this the election where he finally pushes for a turn at being Prime Minister? Like I said, he could become the story of this election year. LISTEN ABOVESee omnystudio.com/listener for privacy information.

The Minister for Trade's attempting to put to bed concerns about our Free Trade Agreement with India, repeatedly voiced by the NZ First leader. Winston Peters claims it will let tens of thousands more Indian migrants enter the country. The Prime Minister has denied the assertion. Todd McClay told Mike Hosking there are no rights around migration in the agreement – instead it allows skilled workers to come to New Zealand for a limit of three years. He says trade deals are complicated and complex, but we do very well out of this deal. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Winston Peters claims our proposed trade agreement with India would let visa holders bring family members with them. The Trade Minister denies the FTA could allow 20,000 to 25,000 more immigrant arrivals. Peters says Todd McClay admitted the loophole himself to a select committee. "He had to concede that there were those people who had the right to bring their spouses and their children right away." In the hearing, McClay said the FTA extends standard visa settings. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Episode Title: Trade & Tech Series: Using Technology to Unlock Duty Mitigators Hosts: Renee Chiuchiarelli & Julie Parks (Hammer & Heels) Published Date: January 27, 2026 Episode Length: ~11 minutes Series: Trade & Tech

- Tổng Bí thư Tô Lâm thăm, chúc tết công nhân Ngành than tại Quảng Ninh.- Chủ tịch nước Lương Cường yêu cầu chuẩn bị tốt các điều kiện phục vụ nhân dân vui xuấn, đón Tết Bính Ngọ.- Hà Nội bổ sung 30 nghìn tỷ đồng vào tổng mức vốn Kế hoạch đầu tư công năm 2026.- Chỉ số hạnh phúc - Thước đo nâng cao toàn diện đời sống người dân Lào Cai.- Việt Nam chưa ghi nhận ca nhiễm virus Nipah, Bộ Y tế tăng cường giám sát và phòng dịch từ sớm.- Trong khi đó, Ấn Độ bác thông tin về 5 ca nhiễm virus Nipah ở bang Tây Bengal. Dịch bệnh vẫn đang được nhà chức trách của nước này giám sát chặt chẽ.-  Sau gần hai thập kỷ đàm phán kéo dài, Liên minh châu Âu (EU) và Ấn Độ hoàn tất các vòng đám phán về Hiệp định Thương mại Tự do (FTA) mang tính lịch sử.- Bão tuyết khiến hàng chục người thiệt mạng, Mỹ tiếp tục đối mặt thời tiết khắc nghiệt đến đầu tháng Hai.

New Zealand is going to sign this free trade deal with India. The massive boost we got and still enjoy from Phil Goff's signing of the China FTA is still very much fresh in mind. Hipkins sounds pretty upbeat about it, with a few questions to be asked, but he says caucus will look at it and make a decision. Of course, it'll need support across the aisle because NZ First isn't keen. The Europeans have just done a massive deal with Delhi overnight. Ursula von der Leyen is in India, getting the red carpet treatment from Modhi. Combined they make up 25% of the world's GDP and the market size? Two billion people. They've been negotiating for years and years, but finally have a deal, in part because of a Trump's tariffs but also because India has managed to secure protections for dairy. They say Delhi "has prudently safeguarded sensitive sectors, including dairy…”. We generally treat trade as a bipartisan issue and there's little reason to think this deal will be any different - barring any major red flags with the details, many of which we the public don't know yet but that the Opposition's being consulted on. But if that checks out, it's probably going to be a rubber stamp. After all, we're like the world's FTA cheerleaders. We basically go round international meetings with a clipboard trying to sign people up. We now have 70% of our global trade covered by FTAs. It's reasonable to only expect that will increase. And perhaps easier once Trump leaves office, too.See omnystudio.com/listener for privacy information.

Gold continues its upward trajectory, bypassing the $5,000/oz for the first time ever as investors seek security due to geo-political risks. President Trump threatens Canada with 100 per cent tariffs sho8uld is seal a trade deal with China but Prime Minister Mark Carney says he was not pursuing an FTA with Beijing. A partial U.S. government shutdown looms as Democrats are set to vote against an ICE funding extension after a second fatality by federal agents in Minneapolis.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Host Tushar Shetty sat down with Dr. Tobias Scholz, South Asia researcher at the German Institute for International and Security Affairs (SWP) in Berlin, to examine the rise of India-EU relations and the significance of their soon-to-be-signed FTA and Security & Defense partnership. They discuss how both U.S. partners, facing President Trump's hostile and erratic foreign policy actions, accelerated their long-awaited FTA, the reexamination within Europe about its dependence on the United States and its role in the world, and how India and the EU handled tricky negotiations and overcame mutual disagreements to sign “the Mother of all Deals.”To find out more about the upcoming ISA-SAWP Conference, you can reach out to SAWP2026@isanet.org or go to https://www.isanet.org/Conferences/SAWP-Colombo-2026/Call

कर्तव्य पथ पर भव्य परेड में ऑपरेशन सिंदूर की सैन्य शक्ति, राष्ट्रपति द्रौपदी मुर्मू ने शुभांशु शुक्ला को अशोक चक्र से सम्मानित किया, राजनीतिक मोर्चे पर अखिलेश यादव ने संविधान का मुद्दा उठाया, कर्नाटक में मनरेगा को लेकर कांग्रेस के आंदोलन और राज्यपाल–सरकार विवाद ने तूल पकड़ा, लखनऊ में KGMU की मजारों को लेकर विरोध तेज हुआ और नागौर में पुलिस ने भारी विस्फोटक सामग्री बरामद की। मौसम विभाग ने कई राज्यों में बारिश और हिमालयी क्षेत्रों में बर्फबारी का अलर्ट जारी किया है। अंतरराष्ट्रीय स्तर पर अमेरिका ने भारत को गणतंत्र दिवस की शुभकामनाएं देते हुए क्वाड सहयोग की सराहना की, कनाडा ने चीन के साथ FTA से इनकार किया, जबकि टी20 वर्ल्ड कप को लेकर पाकिस्तान की भागीदारी पर अनिश्चितता बनी हुई है।सिर्फ़ 5 मिनट में सुनिए दोपहर 1 बजे तक की बड़ी ख़बरें

Kia ora,Welcome to Tuesday's Economy Watch where we follow the economic events and trends that affect Aotearoa/New Zealand.I'm David Chaston and this is the international edition from Interest.co.nz.Today we lead with news repricing for American risk is underway, evidenced by rising UST yields, a falling US dollar, and commodity price spikes.First up today, American durable goods orders rose in November by more than expected to be +10.5% higher than year ago levels, a gain that has impressed markets, and came as a complete surprise. Non-defense capital goods orders, excluding aircraft, were up +4.3%, also a good gain.But there are a number of factors we should take into account when assessing this data. It is 'nominal' and not inflation adjusted and tariff-taxes will be a part of the increase. Second, we looked back at the ISM and S&P Global factory PMIs for November and they did not pick up this type of gain. The ISM one actually reported contraction, the S&P Global and unchanged expansion. And then there is the 'new management' at the US data agency that releases this data. All three factors mean we should wait a bit to see if this is an outlier result. Risks abound.Meanwhile, the Chicago Fed's National Activity Index came in below trend in November, although not as negative as it was in October. This is the ninth below-trend reading in the past twelve months.It was a similar story for the Dallas Fed factory survey, which also recorded a pullback, for January, although not as steeply as it did in December. Output and new orders rose, but the overall index was held back by a sharp jump in prices paid for inputs. Only about half that was recovered by prices received even though that rose sharply too.There was a US Treasury bond auction today and while it was well supported, it did bring a notable rise in the yield achieved. The 2 year bond delivered a yield of 3.55% at todays event, up from 3.45% at the prior equivalent event a month ago. This is the largest shift in yields we have observed at these events in more than a year. The US's ballooning deficit can't really afford rising interest rates, but then again it couldn't afford the tax cuts for the rich either.Singapore's industrial production dipped rather sharply in December to end up +8.3% from the same month a year ago. But the December pullback was less than observers had expected.In addition to Auckland, and Australia, Monday was also a public holiday in India, Republic day. And the two top EU officials were in New Delhi to seal a key trade deal between the two economic powers. In fact, it has been called "the mother of all deals" and is set to be signed later today. Both sides are making major concessions to get it done and it is likely to boost trade in a globally significant way. The EU will get major access to India's car market. India will get the EU's preferential tariff MFN treatment.The UST 10yr yield is now just on 4.21%, down -3 bps from this time yesterday.The price of gold will start today at US$5087/oz, up +US$104 from yesterday and a new record again. Silver is up proportionately more, up +US$12/oz at US$115/oz and also a record high. Platinum has risen to US$2857/oz, up +US$116/oz.Tin prices are up +9.5% today, and copper is up +1.5%. Both build on recent surges to record highs. A falling greenback accentuates these rises, but all commodities are still priced in USD.American oil prices are holding at yesterday's at just under US$61/bbl, while the international Brent price is firmish, now just under US$65.50/bbl and down -50 USc.The Kiwi dollar is up +30 bps from yesterday, now at 59.7 USc. Against the Aussie we are up +10 bps at 86.4 AUc. Against the euro we are also up +10 bps at just on 50.4 euro cents. That all means our TWI-5 starts today just under 63.5, and up +40 bps from yesterday, its highest since late September.The bitcoin price starts today at US$87,677 and down just -0.3% from this time yesterday. Volatility over the past 24 hours has been modest at just under +/- 1.4%.You can get more news affecting the economy in New Zealand from interest.co.nz.Kia ora. I'm David Chaston and we'll do this again tomorrow.

Thanks to Monarch for partnering with me! Get 50% off your first year by using my link https://monarchmoney.yt.link/eB2fzzP or discount code euro50 when signing up for a free trial! Welcome to calm, confident money! #monarchpartnerChinese retail sales just did something they've never done before outside of the lockdowns. At the same time, capital investment continues to legitimately crash, December was third month in a row of steep declines leading to the first yearly negative for it in China's modern history. The only thing, the ONLY thing, keeping the economy from completely falling off a cliff is China selling everything it can everywhere else, especially in Europe. Eurodollar University's Money & Macro AnalysisChina NBS Basic Situation of National Fixed Asset Investment in 2025https://www.stats.gov.cn/sj/zxfb/202601/t20260119_1962326.htmlChina's economy looks more resilient than it feels as a property slump drags onhttps://apnews.com/article/china-economy-property-tariffs-jinping-17e9a32cf105764f457c1111f185dd3fMacron threatens tariffs on China "in the coming months" due to trade surpluseshttps://fr.tradingview.com/news/forexlive%3A3395740c5094b%3A0-macron-threatens-tariffs-on-china-in-the-coming-months-due-to-trade-surpluses/Tariffs of up to 50% go into effect, hitting imports from China, other non-FTA countrieshttps://mexiconewsdaily.com/news/mexico-tariffs-go-into-effect-china/https://www.eurodollar.universityTwitter: https://twitter.com/JeffSnider_EDU

Fresno Unified leadership contacted Community Medical Centers leadership and scheduled a meeting for this morning. District and FTA leadership met to discuss the negative impact the stalled negotiations between Community and Aetna is having on retirees. Please Like, Comment and Follow 'Philip Teresi on KMJ' on all platforms: --- Philip Teresi on KMJ is available on the KMJNOW app, Apple Podcasts, Spotify, YouTube or wherever else you listen to podcasts. -- Philip Teresi on KMJ Weekdays 2-6 PM Pacific on News/Talk 580 AM & 105.9 FM KMJ | Website | Facebook | Instagram | X | Podcast | Amazon | - Everything KMJ KMJNOW App | Podcasts | Facebook | X | Instagram See omnystudio.com/listener for privacy information.

Tom Haberstroh and Dan Devine discuss Jaylen Brown's $35,000 fine after calling out the NBA refs, break down how the lack of foul shots is impacting the league in the new year and ask what can be done to end the scoring drought.Next, they dive into the latest NBA trade deadline rumor mill news. The duo breaks down Rich Paul's comments surrounding a potential Austin Reaves trade and gives their thoughts on the best fit for Ja Morant.Later, they react to Giannis being booed by his home crowd. Should the Bucks trade Giannis for Jalen Johnson? Plus, they discuss Anthony Davis not undergoing surgery for his hand injury and confirm he is back on the trade block. Where would he fit best?1:12 - The Big Number: $35,000 - Jaylen Brown's fine for criticizing refs3:50 - NBA scoring drought: What's causing the slump?15:57 - The Little Numbers: 77 - 3-shot fouls called since January 1st22:11 - The Little Numbers: 12 - teams with at least 17% of total points from free throws26:43 - The Little Numbers: 3.4% - OKC's FTA rate increase in the new year30:49 - Latest with the trade deadline32:41 - What's next for Ja Morant?37:37 - Anthony Davis back on the trade block47:10 - Giannis gets booed by home crowd

Beef + Lamb New Zealand’s chairwoman on how the summer has been for farmers so far, and the FTA with India. Beef + Lamb NZ turns 75 this year. What's on the cards?See omnystudio.com/listener for privacy information.

The chief executive of Horticulture NZ on fruit fly detection in Auckland, an FTA with India, and HortNZ’s priorities and predictions for 2026.See omnystudio.com/listener for privacy information.

David Jernigan 0:15Hello! Dr. Deb 0:16Hi there, sorry for all the confusion. David Jernigan 0:19Oh, no worries, you gotta love it, right? Dr. Deb 0:21Oh, I can’t hear you. David Jernigan 0:23No way, let’s see, my mic must be turned off? Dr. Deb 0:27Hang on, I think it’s me. Let’s see…Okay, let’s try now. David Jernigan 0:40Okay, can you hear me? Dr. Deb 0:42Yep, I can hear you now. David Jernigan 0:43Excellent, excellent. And, how are you today? Dr. Deb 0:48I am good, thank you. How about yourself? David Jernigan 0:50I’m good. Well, it’s good to finally meet you and get this thing rolling. Dr. Deb 0:56Yes, yes, I’m so sorry about that. David Jernigan 0:58That’s alright, that’s alright.So… Dr. Deb 1:01Yeah, go ahead. David Jernigan 1:03So, tell me about yourself before we get going. Dr. Deb 1:06Yeah, so I am a nurse practitioner. I’m also a naturopath. I have a practice here in Wisconsin. I’ve been treating Lyme for about 20 years, so I’m really excited to have this conversation and learn what you’re doing, because it’s so exciting and new. David Jernigan 1:21Well, thank you. Dr. Deb 1:22Yeah, so we treat a lot of chronic illness patients, do some anti-aging regenerative things as well, so… David Jernigan 1:30Yeah, I went to your website and saw you guys are killing it, looks like. Dr. Deb 1:35Yeah. David Jernigan 1:35Got a lot of good staff, it looks like. Dr. Deb 1:37Yeah, we’ve got great staff, great patients, busy practice. We have 5 practitioners, so we have about 15,000 patients in our practice right now. David Jernigan 1:46Well, excellent. Yeah. Excellent. Yeah, yeah.So, I’m excited for this discussion. Dr. Deb 1:53Good, me too. So I pre-recorded our intro, so we can just kind of dive right in, and I’ll just ask you to kind of introduce yourself a little bit, tell us a little bit about yourself, and, and then we can just dive right into it. David Jernigan 2:08All right. I’m Dr. David Jernigan, and I own the Biologic Center for Optimum Health in… Franklin, Tennessee, and I’ve been in practice for over 30 years. I shook Willie Bergdurfer’s hand, if anybody knows who that is. It’s kind of infamous now with some of the revelations that have happened about Lyme being a bioweapon and weaponized. But, you know, I’ve been doing this, probably longer than almost anybody that’s still in the business in the natural realm. It chose me. I did not choose Lyme. Matter of fact, there were many times in my career that I was like. You know, cancer’s easier because of the fact that everybody agrees, you know, what we’re dealing with. And in the 90s, it was a whole different reality, where nobody actually understood that you could have Lyme disease and not be coming from New England.You know, so I had actually the first documented case of a Lyme disease, CDC positive.Patient that had never left the state of Kansas before. So they couldn’t say that it wasn’t in Kansas, and so she had actually been, pregnant with… twin boys, and they were born CDC-positive as well, and so it is transmitted across the placenta we know.So, I, you know, the history of how I did all this was, in the 90s, probably 1996, probably, somewhere in there, 97. With this woman, you know, I… if you go into Robin’s pathology books from back then. Which we all used, medical doctors and everybody else studying. you know, there was basically a paragraph about Lyme disease, and on the national board tests, as you recall, it was probably like, what causes, or what is, bullseye rash associated with? And you’d had to guess Lyme disease, of course. Dr. Deb 4:07Female. David Jernigan 4:08But that was, you know, considered to be more a New England illness, and you would never see it anywhere else. But here was this woman. I knew… nothing about Lyme beyond what we had gotten taught in college, which was, like I say, next to nothing. And she would not let me stop feeding me information. I mean, you gotta remember, the internet wasn’t even hardly in existence in those years. I mean, it was brand new. It was supposed to be this information highway, and So I started purchasing, like a lot of doctors do even now, they start purchasing every kind of new supplement that’s supposed to work for bacteria. There was no product in those days that actually was Lyme-specific. I mean, nobody was really dealing with it naturally. It was always a pharmaceutical situation. Dr. Deb 5:04And a very short course at that. David Jernigan 5:06Yeah, 2 weeks of doxy and you’re cured, whether your symptoms are gone or not, which… she’d had the 2 weeks of doxy, and her symptoms and her son’s symptoms were not gone. And so, I absolutely just purchased everything I could find. Nothing would work. I mean, I could name names of products, and you would recognize them, because they’re still out there today. Dr. Deb 5:28Which is. David Jernigan 5:30Kind of a… A sad thing that natural medicine is still riding on these things that have the most marketing. Dr. Deb 5:37As opposed to sometimes the things that actually have the documented research. David Jernigan 5:42Behind it, and I am a doctor of chiropractic medicine, and I specialized all these years in chronic, incurable illnesses of all types. That may sound odd to a lot of people, but doctors of chiropractic medicine are trained just like a GP typically would be. The medical schools, as I understand it, got together, decades ago and said, wow, if all we did was… Crank out general practitioners for the next 10 years, we wouldn’t have still enough general practitioners to supply the demand. Dr. Deb 6:17Right. Everybody in medicine, in medical schools, wanted to be a specialist, because that’s where the money was, and it was… David Jernigan 6:24Easier, kind of, also, to… you know, just focus on one part of the body, and specialize in that. Dr. Deb 6:31Expert in that one area. David Jernigan 6:32So we all now have the same training. We all go through pre-med. We got a bachelor’s degree, I got my bachelor’s degree in nutrition, and through, Park University in Parkville, Missouri. And so, you know, when I ran out of options to purchase, I just used a technology that I developed, which was an advancement upon other technologies, but I called it bioresonance scanning. And I coined the term back in the 90s. It was a way to kind ofKind of like a sensitive test, you know, like you might. Dr. Deb 7:09I wouldn’t. David Jernigan 7:09Of applied kinesiology, then clinical kinesiology, then chiro plus kinesiology, then, you know, you can just keep going with all the advancements that were made. Well, this was an advancement upon those things, so… I developed… I was the first in… in… my known world of doctors to develop a way to detect adjunctively, obviously we can’t say it’s a primary diagnosis. Adjunctively detect the presence of a given specimen. So we could say, thus saith my test. It’s highly likely you have Borrelia burgdurferi. And, but I had to have the specimen on hand to be able to match what I call frequency matching to the specimen. Brand new concept in those days. And so I was able to detect whether or not my treatments were successful or not. This is something even now that’s really difficult for doctors, because antibody tests, even the most advanced ones, it’s still an antibody test. It’s still an immune response to an infection.And accurately, you know, some doctors will slam those tests, saying, well. That doesn’t mean you actually have the infection, that just means your body has seen it before, which is a correct statement, kind of. So being able to detect the presence, and even where in the body these infections are was a way huge advancement in the 90s, for sure it’s kind of funny, I think about a conference I went to, and cuz… I’m kind of jumping ahead. Because I ended up developing my own formula, just for this woman and her children, and it worked. And I was like, wow! Their symptoms were gone, all the blood tests came back negative. In those days, we were using the iGenX. Western blot, eventually. And the, what was called a Lyme urine antigen test. I don’t know if you remember that, because it… Only decades later did I meet, the owner of iGenX, Nick Harris. Dr. Deb 9:17Person. And I was like, whatever happened to the Luwat test? Because I took it off the market after a while. He said, honestly, we lost the antigen and couldn’t find it again. Oh, no. David Jernigan 9:27And so… but that was a brilliant test. It was the actual gold standard in those days. Again, the world… it can’t be understated how different the world was in the 90s. Dr. Deb 9:40Yeah. David Jernigan 9:41Towards natural medicine, even. Dr. Deb 9:44Oh, yeah. We think… we think it’s bad now, but, like, when I started, too, I started in the early 2000s, like, we were all hiding under the radar, like, you didn’t market, we would have never been on social media, we didn’t run ads, we didn’t do any. David Jernigan 10:00Right. Dr. Deb 10:01Because the medical boards were coming for us. David Jernigan 10:04Came after me. Dr. Deb 10:05Because I had the word Lime on my page, my website. David Jernigan 10:10You know, not saying that I treat Lyme. Dr. Deb 10:13Hmm? David Jernigan 10:13Yes Dr. Deb 10:15Just talking about mind. David Jernigan 10:16And it’s funny, because, once I had this formula, it was something… and I trained in Germany, in anthroposophical medicine, and they’ve been trained in herbal… making herbal extracts, making homeopathic remedies in the anthroposophical methodology, and I trained with the Hahnemann versions of homeopathy, which is just slightly different. Yeah. And, so I was well-versed with making some of my own formulas by that time. And so, it was really something that I wrote on the bottle, you know, and I had to call it something, so I called it Borreligin, which is still in existence, and it’s still a phenomenal herbal remedy right now. And to my knowledge, it’s the only frequency-matched herbal formula. Maybe still out there. Because unless you knew how to do my testing, the bioresonent scanning, there was no way to actually do frequency matching. Matter of fact, as a really famous herbalist attacked me online, saying, oh, none of these herbs will kill anything. And I’m like, that wasn’t what I was saying. I was saying, back in those days, I was saying, well, if… what would the body need to address these infections?You know, not, like, what’s gonna kill the infections for the body. Dr. Deb 11:38Right. David Jernigan 11:39Right? So it was a phenomenal way, but the LUAT test was amazing because what you’d do is you would give your treatment, like an MD would give an antibiotic for a week, ahead of time. Trying to increase the number of dead spirochetes showing up in your urine one day out of 3 days urine catch. So you’d wake up in the morning, you’d collect your urine 3 days in a row, and any one of those being positive is a positive. But it was a brilliant test because it wasn’t an antibody test. They were literally counting the number of dead pieces of Lyme bacteria in your urine. I mean, it was pretty irrefutable. So I had a grand slam on the… the Western blot on patients, and I’d also have a grand slam on the LUAT, and their medical doctors would say, oh, that doctor in the lab are probably in cahoots change some lab. Dr. Deb 12:38Of course. David Jernigan 12:39That come in. And I still see that today. You know, it’s like, oh my gosh, the better the tests are getting. There’s still a bias if you do your own research. Well, if you happen to be a doctor who loves research. And you’re a clinician, so you actually treat patients who’s gonna write the research study? Well, of course, the doctor who did the study, well, he’s biased, and I’m like, I still can’t influence lab tests. Well, lab tests aren’t everything. People scream over the internet at me. It’s like, well, a negative lab test doesn’t mean anything. I was like… I get that with the old Western blot testing. Dr. Deb 13:16Right. David Jernigan 13:16The more sensitive tests, which are very close to 100%, Sensitivity, and 100% specificity. So, meaning, like, they can… if you have the infection, they’re gonna find it. Dr. Deb 13:30They’ll find it, yeah. David Jernigan 13:31And if they… if you have the infection, they’re going to be able to tell you exactly 100% correctly what kind of infection it is. Back in those days, you couldn’t, you could just count the dead pieces, which was… Dr. Deb 13:43Yeah. David Jernigan 13:43Significant, but It’s funny, because when medicine does that, you know, mainstream medicine that’s backed by all the nice foundations who donate millions of dollars towards the research. Their negative tests are significant, but if you fund your own, Yours isn’t that significant. Dr. Deb 14:04Right, or what if we call something a seronegative autoimmune disease, like lupus or rheumatoid arthritis, because none of the tests are positive, but you have all the symptoms. Here, let me give you this $100,000 a year drug. David Jernigan 14:19Yeah. Dr. Deb 14:19And instead of looking for what might actually be causing the symptoms. That’s all okay, but what we do is not okay. David Jernigan 14:27Right. Yeah, it’s a double standard, and it’s getting better. I want to do… tell the world it is getting better. Some of the dinosaurs are retiring. Dr. Deb 14:36No. David Jernigan 14:37Way for people who are… Are more open-minded to new ideas. But, getting back to that woman, she… that formula that I made just for her and her son, I… She went online. Dr. Deb 14:54Which, I had never been on a news group. David Jernigan 14:58Not even sure I knew what one was, you know? Imagine, I’m kind of that dinosaur that… Cell phones were, like, these really big things with a big antenna sticking out of it, and… Dr. Deb 15:09Nope. David Jernigan 15:10So I thought I was pretty hot stuff, just that I actually had a computer software program that was running my front desk. And even then, it was an Apple IIe computer. Dr. Deb 15:21Right. David Jernigan 15:22Probably be pretty valuable right now if I’d kept it, but… Dr. Deb 15:25Mmm… David Jernigan 15:26It being an antique. But, suddenly people were calling my clinic, because the lady with the twin boys that was well was telling people on these research, I mean, these Lyme disease forums and boards online. And, I started going, oh my gosh, you know, as a doctor, it’s one thing to treat a person in your clinic, it’s a different thing to have your clinic name on the label. Like, we all do, Even now, and you’re supposed to write everything that’s on the label, and… all these guidelines, and I’m like, wow, I need to split this off. I mean, I def… I definitely want to help people, and this is… I was pretty excited about the results we were getting. Pre-treat… Pre-treatment and post-treatment. And, so… that’s where I developed, my nutraceutical business in the 90s called Journey Good Nutraceuticals. My advice to anybody thinking about doing the same thing, don’t put your last name on it. Dr. Deb 16:25– David Jernigan 16:25You know, because anytime negative anything comes out, there goes the Jernigan name, you know, the herbal, you know, there’s just all these, and especially nowadays, with all the bots that are just designed to slam natural medicine. Dr. Deb 16:38Yeah. David Jernigan 16:39And that is out there in a… and just ugly people. Dr. Deb 16:42Or should we just say, people with a different opinion? How’s that? David Jernigan 16:46Yeah. That are being less than supportive. Dr. Deb 16:49But. David Jernigan 16:51It was amazing, because by 1999, I presented my research, my first research, I’d never done research. This is what I would… I would say to a lot of people who go, my doctor did… I don’t know, my doctor doesn’t know what you’re doing, my doctor… I was like going, you know, most doctors don’t do research. They don’t publish anything. Their opinion is their opinion, but they don’t back it up in peer review, right? And so that’s what I always tried to do, was back it up in peer review and publish. And so, in 1999, I presented at the International Tick-Borne Diseases Conference in New York City. I’m telling you, it was like the country boy going to the city, you know, I got my… I got my suit on, and I looked all right, and my booth was wonderful, and all these different things, and it was just a big wake-up call.Because what we had demonstrated… let’s get back to the… and this was what I demonstrated with that first study. was that… A positive LUAC test, that Lyme urine antigen test for my Gen X, was a score of 32. Meaning, one of those 3 mornings urine had 32 pieces in the amount of urine they checked of deadline bacteria spirochetes. Okay? Okay. With antibiotic challenges, a highly positive was a score of 45. Dr. Deb 18:19Wow when I would give one dropper 3 times a day for a week. David Jernigan 18:24Ahead of time, and then do the person’s LUAT test, We were getting scores 100, 200… And at that point, we only had a couple, but we had a couple that were greater than 400. Yeah, dead pieces, where the lab just quits counting. They just said, somewhere over 400, right? Dr. Deb 18:45Yeah. David Jernigan 18:46Which, when the medical system at the conference, you know, I was the only natural doctor in the world that was… had any kind of proof of anything naturally that could outperform antibiotics. Can you imagine? Dr. Deb 18:59Yeah. And… David Jernigan 19:01They were just, oh my gosh, incredulous. They’re like, I’ve given the most… one guy came up to me, and to my face, and he goes, I’ve given the most aggressive antibiotic protocols And I’ve only seen one patient over 100. I was like, that makes this pretty significant, doesn’t it? But, it didn’t just, like, make us take off, because guess what? In Lyme world, if a pharmaceutical antibiotic made you feel horrible. That meant it was working. Dr. Deb 19:28That’s right. We used to, back in the day, if you didn’t herx. And had that horrible die-off reaction, for those of you who don’t know what a herx is, but if we didn’t make you herx, we weren’t doing our job right. David Jernigan 19:40You’re looking for your patients to feel horrible, and sometimes to the level of committing suicide. Dr. Deb 19:46Yes. David Jernigan 19:47So bad. Dr. Deb 19:48Yes. David Jernigan 19:49And I was the first doctor, I think, in the world to start screaming and hollering and saying, stop using the worsening of your patient’s symptoms as a guide to good treatment, because they’re… I wasn’t seeing it with my formulas. Because I was doing a comprehensive program of care. I think I was also one of the first doctors to say, we need to detoxify these people as we’re doing this. And you would sit there and say, well, sure you were. I was like, well, remember, there wasn’t a lot of communication. There wasn’t anybody on the internet saying, do this, do that. And, It was, it was interesting in those days. It was, how do you… How do you help the world heal from these things? That they don’t know they have. So later, I actually had a beautiful booth at a health… a big health expo in Texas, I remember, and I was like, you know, you spend a lot of money on the booth, and… Dr. Deb 20:43Yup. David Jernigan 20:43And you’re thinking about it because you’re funding the whole thing, you say, wow, if I only sell one case, I’ll at least cover my cost. Dr. Deb 20:51Yep. Yeah, you’re great. David Jernigan 20:52And I had this beautiful banner of, like, a blown-up tick’s mouth under microscope. You know those beautiful pictures of, like, all the barbs sticking out, and how they anchor themselves in your skin, and… And, thousand people walking by my booth, and they’re just like, keep walking, because they didn’t know they had Lyme. There was, like, and they had MS, maybe, but they don’t have Lyme, and so they just would keep walking. Nobody even knew. Why would I go to a conference in Texas? And I’m trying to say, no, guys, it’s everywhere. Dr. Deb 21:24Yeah. David Jernigan 21:24And… and everybody, you know, yes, you probably have this, you know, kind of thing. If you’re… if you… are chronically ill, almost, of any kind of way. You know, kind of trying to tell people this was… Again, in Robin’s pathology textbooks, one of the few things that it did tell you about Lyme was that it was called the Great… the New Great Imitator. Because it would imitate up to 200 or more different illnesses. So, it’s been an interesting journey, of… educating people, writing articles, but it was interesting, the lady who I first fixed, Laboratory verified, everything like that, symptoms went away, all that kind of fun stuff. Her children were fine, they’ve been fine for years now. When she went on the newsboards in the Lyme disease support groups, It created a war. Oh my goodness, it was like, how dare you? And, say that something natural might actually help, right? Dr. Deb 22:30Right, exactly. David Jernigan 22:32And, I even had… A… one of those first calls to… with a marketing company at one point, way a long time ago. And the lady got on the phone, the owner of the marketing company goes, I would have blood on my hands if I actually took your clinic on. Yeah, you can’t treat Lyme disease, and… Even the big, big associations that are out there are still largely that way. I mean, they’re getting better, but it’s just like… you know, a lot of the times, it’s herbs are good. Herbs will help. Good, you know, but they’re safe. So, it’s still a challenge to… to… present in mainstream Lyme communities, even. Because there’s this… Fear of doing anything outside of antibiotics. Dr. Deb 23:32Yeah, so let me ask you this. From your perspective. Why do you think so many chronic infections exist these days, like Lyme and the co-infections, Babesia, Bartonella, mold illness? And we talked a little bit about herbs and why they, antibiotics and things like that fail, but let’s talk a little bit about that. David Jernigan 23:53So, it’s fascinating. When I trained in Germany, they said that we, as humanity, has moved away from what they called the inflammatory diseases. You know, in the old days, it was. Lots of high fevers, purulent, pus-generating bacterial infections. And I said, as a society, we have… Dr. Deb 24:14Have shifted from those to what they call cold sclerotic diseases, which are your… David Jernigan 24:21Cancers, your diabetes, your atherosclerosis, your… and they said, we’re starting to see what used to only be geriatric diseases in our children. That’s how bad it’s gotten. We have suppressed fevers, we don’t… we don’t respect the wisdom of the human body. So, you know, the doctors say, step aside, body, I will fix this infection for you with this antibiotic. And so, what we’ve done with the, overuse of antibiotics, and this isn’t me just talking from a natural perspective, this is… Right, it’s everybody around the world is acknowledging. I’ll show you… I could show you a, a presentation, if we can do a screen-sharing situation. Yeah. About the antibiotic situation in the world, because it’s really concerning. But what I would say, and kind of like an advancement forward, is we are seeing mutated bacteria. You know, they talked about… do you remember when they found the Iceman, you know, the… You know, the prehistoric guy that’s… In the eyes, and he had Lyme bacteria. I was like, he had spirochetes, maybe. Dr. Deb 25:33Yeah. David Jernigan 25:33That isn’t a modified, mutated version. That’s just maybe the… Lyme… you know, Borrelia… call it Borrelia something, you know, it’s a spirochete, but what we’re dealing with today. Even under strep or staph, as you know, you know, Pseudomonas aeruginosa, you name it, whatever kind of infection a person has is not the same bacteria that your grandparents dealt with. Dr. Deb 26:01That’s right. David Jernigan 26:32It’s a much mutated, stronger, more resistant to treatment type of thing. So, I think that’s one reason. I think the, It’s great that we’re seeing, you know, Secretary Robert F. Kennedy Jr. bringing awareness to things that Like it or not, yeah, seed oils do create inflammation, and everyone in the natural realm, as you know. Has been trying to say this for probably how long? Dr. Deb 26:35Yeah, 25, 30 years. 20 years each. David Jernigan 26:48Yes. You know, thank goodness for people like Sally Fallon and her beautiful book, Nourishing Traditions, that started you know, Dr. Bernard Jensen’s books way back in the day, Dr. Christopher’s books way back in the day. Dr. Deb 26:48Damn. David Jernigan 26:49You know, all of them were way ahead of their time, saying, by the way, your margarine is only missing one ingredient from being axle grease. Dr. Deb 26:58Yeah. David Jernigan 26:58I think that was Dr. Jensen saying that at one point, probably 50, 60 years ago, I don’t know. Dr. Deb 27:03Yep. David Jernigan 27:04So, we’ve created this monster. We, we live in a very controlled environment, you know, of 72, 74 degrees at all times, we don’t sweat, we don’t have to work that hard, typically. You know, most of us aren’t out there like our ancestors were, so that’s making us more and more… Move towards the cold sclerotic diseases, of which even Lyme disease is, you know, which… Yes, it has inflammation, yes, but as a presentation, it’s very often associated with some of these Cold sclerotic diseases of mankind that we see now. Dr. Deb 27:46You have it. David Jernigan 27:47Yeah. Dr. Deb 27:48So, tell me, what is phage therapy? David Jernigan 27:52Well, may I show you a cool video? Dr. Deb 27:55Yeah, I’d love that. David Jernigan 27:56I did not make this video, this is just one of my favorites, because it’s from the National Institute of Health. Let’s see if I can just… Click the share screen thing. And get that to pop up. That’s not what I’m looking for, but it’s gonna be soon. Let’s go here… Alright, can you see that? Dr. Deb 28:18Yeah. David Jernigan 28:19Okay. Modern medicine faces a serious problem. Thanks in part to overuse and misuse of antibiotics, many bacteria are gaining resistance to our most common cures. Researchers are probing possible alternatives to antibiotics, including phages. So, bacteriophages, or we like to call them phages for short, are naturally occurring viruses that infect and kill bacteria. The basic structure consists of a head, a sheath, and tail fibers. The tail fibers are what mediate attachment to the bacterial cell. The DNA stored in the head will then travel down the sheath and be injected inside the cell. Once inside the cell, the phage will hijack the cellular machinery to make many copies of itself. Lastly, the newly assembled phages burst forth from the bacterium, which resets their phage life cycle and kills the bacterium in the process. Someday, healthcare providers may be able to treat MRSA and other stubborn bacterial infections using a mixture of phages, or a phage cocktail process would be first to identify what the pathogen is that’s causing the infection. So the bacterium is isolated and is characterized. And then there’s a need to select a phage in a process known as screening of phage that are either present in a repository or in a so-called phage library. That allows for many of the phages to be evaluated for effectiveness against that isolated I don’t know, bacterium. Phages were first discovered over 100 years ago by a French-Canadian named Felice Derrell. They initially gained popularity in Eastern Europe, however, Western countries largely abandoned phages in favor of antibiotics, which were better understood and easier to produce in large quantities. Now, with bacteria like these gaining resistance to antibiotics, phage research is gaining momentum in the United States once again. NIAID recently partnered with other government agencies to host a phage workshop, where researchers from NIH, FTA, the commercial sector, and academia gathered to discuss recent progress. NIH… So… That is… That is what phage therapy in… is. in what I call conventional phage. Let’s see, how do I get out of the share screen? Hope you already don’t see it. Dr. Deb 30:58Yep, at the top, there should just be a button. David Jernigan 31:00I don’t. Dr. Deb 31:00Stop sharing, yeah. David Jernigan 31:01So… Conventional phage therapy, as you just saw, is a lot like what it is that we’re doing, only the difference is they’re taking wild phages from the environment. They’re finding phages anywhere there’s, like, a lot of bacteria. And then they isolate those phages, and like he said, the gentleman at the very end said we put them in a library, and so there are banks of phages that they can actually now use, and One of the largest banks that I know of has about 700 different bacteriophages, or phages. In their bank that they can pull from. Dr. Deb 31:43Wow. Do you want to take a guess? David Jernigan 31:46How many bacteriophages they’ve identified are in the human gut, on average? Dr. Deb 31:52Oh my god, there’s gotta be more… David Jernigan 31:53Kinds, different kinds of phages, how many? Dr. Deb 31:56There’s gotta be millions. David Jernigan 31:57Well… In population, there’s… humongous numbers, numbers probably well beyond the trillions, okay? Hundreds of trillions, quadrillions, maybe, even. But in the gut, a recent peer-reviewed journal article said that there were 32,242 different types of bacteriophages that live naturally in your intestines, your gut. Dr. Deb 32:25Boom. David Jernigan 32:2632,000. Okay, so… If you read any article on phage therapy that’s in peer review, almost every single one in the very first paragraph, they use the same sentence. They go, Phages are ubiquitous in nature. They’re ubiquitous in nature. So my brain, when I find… when all this finally clicked together, and when we clicked together 5 years into my research, I could not get it to work for 5 years. I just kept going. But that sentence really got me going. I was, like, going, you know. If you look at what ubiquitous means, it says if Phages were the size of grains of sand. Like sand on the beach. They would completely cover the earth and be 50 miles deep. How crazy is that? Dr. Deb 33:24Wow. David Jernigan 33:25That’s how many phages are on the planet. There’s so many… they outnumber every species collectively on the planet. So, it’s an impossibility in my mind. I went, huh, it’s an impossibility that… You catching a, a sterile Bacteria, it’s almost an impossibility. Since the beginning of time, phages have been needing to use a reproductive host. And it’s very specific, so every kind of bacteria has its own kind of phage it uses as a reproductive host. Because phages are… and this is a clarification I want to make for people. just like in the old days, we were talking about the 90s, I talked to a veterinarian that had gotten in trouble with the veterinary board in her state. Dr. Deb 34:14Back in the old days. David Jernigan 34:16Because she gave dogs probiotics. And the board thought she was giving the dogs an infection so that she could treat them and make money off of the subsequent infection. Dr. Deb 34:28Oh my god. David Jernigan 34:29Nobody actually had heard of good, friendly bacteria in the veterinary world, I guess she said she had gotten in trouble, and she had to defend herself, that, no, I’m giving friendly, benevolent, beneficial bacteria. Okay, to these animals, and getting good results.So, phages… Are friendly, benevolent, beneficial viruses. That live in your body, but they only will infect a certain type of bacteria. So… What that means is if you have staff.Aureus, you know, Staphylococcus aureus bacteria. That bacteria has its own kind of phage that infects it called a staph aureus phage. E. coli has an E. coli phage. Each type of E. coli has its own phage, so Borrelia burgdurferi has its own Borrelia burgdurferi type of phage, whereas Borrelia miyamotoi alright? Or any of the other Borrelia species, or the Bartonella species, or the… you just keep going, and Moses has its own type of phage that only will infect that type of bacteria. So that’s… You know, when you realize, wow, why are we going to the environment Was my thought. Dr. Deb 35:54Yeah. David Jernigan 34:55Trying to find wild phages and put them into your body, and hopefully they go and do what you want them to do. What if we could trigger the phages themselves that live in your body to, instead of just farming that bacteria that it uses as a host, because what I mean by farming is the phages will only kill 40% of that population of bacteria a day. Dr. Deb 36:20Wow. David Jernigan 36:20And then they send out a signal to all the other phages saying, stop killing! Dr. Deb 36:24It’s like. David Jernigan 36:2560% of the bacteria population left to be breeding stock. It’s kind of like the farmer, the rancher, who… he doesn’t send his whole herd to the butcher. Dr. Deb 36:35Right. David Jernigan 36:36Just to, you know, he keeps his breeding stock. He sends the rest, right? So, the phages will kill 40% of the population every day, just in their reproduction process. Because once there’s so many, as you saw in the video, once the phage lands on top of the bacteria, injects its genetic material into the bacteria, that bacteria genetic engine starts cranking out up to 5,200 phages per bacteria. Dr. Deb 37:06I don’t know who counted all those… David Jernigan 37:08Inside of a bacteria, but some scientists peer-reviewed it and put it out there. that ruptures, and it literally looks like a grenade goes off inside of the bacteria. I wish I’d remembered to bring that video of a phage killing a bacteria, but it just goes, oof. And it’s just a cloud of dust. So, you’re breaking apart a lot of those different toxins and things. So… That’s… That was the impetus to me creating what I did. That and the fact that I looked it up, and I found out that phages will sometimes go… Crazy. I don’t know how to say it. Wiping out 100% of their host. And it could be a trigger, like change in the body’s pH levels, it could be electromagnetically done, you know, like, there’s been documentation of… I think it was, 50 Hz, electricity. Triggering one kind of phage to go… Crazy and annihilate its host population. There’s other ways, but I was, like, going, none of those fit me, you know? It’s not like I’m gonna shock somebody with a… Jumper cable or something to try to get phages to… to do that kind of thing. But the fact that it could be done, they can be triggered, they can switch and suddenly go crazy against their population. But what happens when they kill 100% of their host? The phages themselves die within 4 days. Dr. Deb 38:45Hmm. Because they can’t keep reproducing. David Jernigan 38:47There’s nothing to reproduce them, yeah. Dr. Deb 38:49Yeah. Especially… unless they’re a polyvalent phage, that means a phage that can segue and use. David Jernigan 38:54One or two other kinds of bacteria. To, as a reproductive host. But a lot of phages, if not the majority, are monovalent, which means they have one host that they like to use. And so… Borrelia, so… my study that I ended up doing, and I published the results in 2021, And it’s a small study, but it’s right in there at the high end, believe it or not, of phage research. Most phage research is less than 30 people. In the study. But, we did 26 people.And after one month of doing the phage induction that I invented, which only… Appears to only, induce or stimulate the types of phages that will do the job in your body. I don’t care what kind of phage it is. I don’t care if it’s a Borrelia phage, it may be a polyvalent phage that normally doesn’t use the Borrelia burgdurferi as its number one. Host, but it can. To go and kill that infection. And the fascinating thing is, there was a brand new test that came out at the same time I came out with the idea, literally the same weekend they presented. Dr. Deb 40:1511. David Jernigan 40:15ILADS conference in Boston in 2019. It was called the Felix Borrelia phage Test. So the Felix Borrelia phage test. Because Borrelia are often intracellular, right, they’re buried down in the tissue, they’re not often in the blood that much. And therefore, doing a blood test isn’t really that accurate. But you remember how there’s, like, potentially as many as 5,200 phages of that type erupt from each bacteria when it breaks apart. It’s way easier to detect those phages, because they’re now circulating, those 52, as you saw in the video. 5,200 different phages are now seeking out another Borrelia that they can infect. And so, while they’re out in circulation, that’s easy to find in the bloodstream. So, 77% of the people, so 20 out of 26, were tested after a 2-week period. After only a 4-day round of treatment. Because according to my testing, remember, I can actually test adjunctively to see if I can find any signatures for those kinds of bacteria. And I couldn’t after 4 days, so we discontinued treatment and waited Beyond the 4 days that would allow the phages themselves to die, so we waited about a week and a half.And redid the test. And 77%, so that 20 out of 26 of the people, were completely negative. Dr. Deb 41:50Wow. David Jernigan 41:52Which, you go, well, it’s just a blood test. Well, no, we actually had people that were getting better, like, they’d never gotten better before. We had one woman who was wheelchair-bound, and in two weeks was able to walk, and even ultimately wanted to work for my clinic. I’m just, like, going… Dr. Deb 42:07I didn’t want to write about all that. I wanted to write about the phages. I was like… David Jernigan 42:12article, I probably should have put some of those stories, because, Critics would say, well, you got rid of the infection, maybe, but… Did you fix the Lyme disease? Well, that’s… there’s two factors here that every doctor needs to understand. There’s the infection in chronic illness, there’s the infection, and then there’s the damage that’s been done. Because sometimes I have these people that would come in and say, well, Dr. Jernigan, it didn’t work for me, I’m still in the wheelchair. And I’m like, no, it worked. Repeat lab test over months says it’s gone, it’s gone, it’s gone. It’s like, we would follow, and 88% of the people we followed long-term were still negative, which is amazing to me. Dr. Deb 42:56And then they have to repair the damage. David Jernigan 42:59It’s the damages why you still have your symptoms. And that’s where the doctor has to get busy, right? Dr. Deb 43:06Right David Jernigan 43:06They were told erroneously by their doctor that originally treated them that they’d be well, they’d get out of the wheelchair, if he could actually kill all these infections. Dr. Deb 43:15It’s not true. David Jernigan 43:16Unless it’s caught early. So I love the analogy, and I’ve said it a thousand times.that Lyme disease and chronic infections are much like having termites in the wood of your house. If you find the termites early, then yeah, killing the infection, life goes back to normal, the storm comes and your house doesn’t fall down. But if it’s 20 years later. Killing the termites is still a grand idea. Right. But you have the damage in the wood that needs to be repaired as well. All the systems… when I talk about damage to the wood, I mean, like. All the bioregulatory aspects of the body, how it regulates itself, all the biochemical pathways, the metabolic pathways we all know about, getting the toxins that have been lodged in there for many years, stopping the inflammatory things that have been running crazy. Dealing with all those cytokines that are just running rampant through the body, creating this whole MCAS situation. Which are largely… Dr. Deb 44:21Coming from your body’s own immune cells called macrophages, which are not even… David Jernigan 44:26It’s not… a virus at all, it’s part of the immune system, it’s like a Pac-Man, and research shows that especially in spirochetes. There is no toxin. Now, I wrote 4 books. I think I wrote the very first book on the natural treatment of people with Lyme disease back in the 90s. Why did I write that? Not because I wanted to be famous, it’s a tiny book, actually, the first one was.I was just trying to help people get out of this idea that you will be well when you kill all the bugs. I was saying, it’s… you need to be doing this. If you can’t come to my clinic, at least do this. Try to find somebody that will do this for you. And that ultimately led to a bigger book.as I kept learning more, and I was like, going, well, okay, now at least do this amount of stuff. And you need to make sure your doctor is handling this, this, this, and this. And so, the third book was, like, 500 and something pages long. And then the fourth book was 500 and something pages long, and now they’re all obsolete with the whole phage thing, because this just rewrites everything. Dr. Deb 45:34Yeah. David Jernigan 45:34It’s pretty fascinating. Dr. Deb 45:37Do you think the war on bugs, mentality created more chronic illness than it solved? David Jernigan 45:44Because of the tools that doctors had to use, yes. We’re a minority, we’re still a minority, you and I. Dr. Deb 45:54Yep. Our doctoring… David Jernigan 45:56Methods I never had, and you’d never… maybe you did, but I’d never had the ability to grab a prescription pad and write out a prescription. I had to figure out, how do I get… and this was… and still my guiding thing, is like, how do I identify, number one, everything that can be found that’s gone wrong in the human body. And what do I need to provide that body? Like, the body is the carpenter. That has to do the repair, has to regenerate, has to do everything, has to get… everything fixed right? We can’t fix anything. If you have a paper cut, there isn’t a doctor on the planet that can make that go away. Dr. Deb 46:38Right. David Jernigan 46:39Of their own power, much less chronic illnesses. So, all the treatments are like the screws, saws, hammers, you know the carpenter must be able to use. So a lot of the time, doctors are just throwing an entire Home Depot on top of the carpenter. In the form of, like, bags of supplements, you know, hundreds of supplements, I’ve seen patients walk in my door with two suitcasefuls. And they were taking 70 bottles, 65 to 70 bottles of supplements, and I’d be just like, wow, your carpenter who’s been working for 24 hours a day, 7 days a week. He’s exhausted. There’s chaos everywhere, you don’t know where to. Dr. Deb 47:22Starting. David Jernigan 47:22He goes, you want me to do what with all this stuff? Dr. Deb 47:25Yep, I’ve seen the same thing. People… thousands, you know, several thousand dollars a month on supplements, and not any better. But they’re afraid to give up their supplements, too, because they don’t want to go backwards, either, and… there’s got to be a better way on both sides, the conventional side and the alternative side, although you and I don’t say it’s alternative, that’s the way medicine should be, but… David Jernigan 47:48Right. Dr. Deb 47:49We have to have a good balance on both sides. David Jernigan 47:52And I will say, too, in defense of doctors using a lot of supplements, I do use a lot of supplements. Dr. Deb 47:57Yeah, I do too. David Jernigan 47:58but I want to synergize what I’m giving the patient so that the carpenter isn’t overwhelmed and can actually get the job done. Like, everything has to work harmoniously together, so it’s not that… It’s not the number of supplements, and why would you need a lot of supplements? Well, because every system in your body is Messed up. My kind of clientele for 30 years. Our clientele, yours and mine. Dr. Deb 48:25Yeah. David Jernigan 48:26They have been sick, For decades, many of them. Dr. Deb 48:31Yeah. David Jernigan 48:31And if they went into a hospital, they honestly need every department. They need endocrinology, they need their kidney doctor, they need their… They’re a cardiologists, they need a neurologist, they need a rheumatologist. I mean, because none of those doctors are gonna deal with everything. They’re just gonna deal with one piece of the puzzle. And if they did get the benefit of all the different departments they need, yeah, they’d go out with a garbage bag full of stuff, too. Dr. Deb 48:57Hey, wood. David Jernigan 48:58Only, they’re not synergized. They don’t work together. You’re creating this chemistry set of who knows how much poison. And I want to tell your listeners, and I mean, you probably say this to your patients as well. There is a law of pharmacy that I learned eons ago, and it applies to natural medicine, too. Dr. Deb 49:21Yep. David Jernigan 49:22But the law says every drug’s primary side effect Is its primary action. So, if you listen to TV, you can see this on commercials. I love… I love listening to these commercials, because I’m like, wow. let’s… let’s… I don’t want to say I’ve named Brandon. I don’t know if that’s…Inappropriate to name a name brand, but let’s just say you have a pharmaceutical that is for sleep. After they show you this beautiful scene of the person restfully sleeping and everything like that, they tell you the truth. It’s like, this may cause sleepiness… I mean, sleeplessness. Dr. Deb 50:04Yeah. David Jernigan 50:04Found insomnia. Dr. Deb 50:06And headaches, and diarrhea. David Jernigan 50:08All the other things, and if it’s an antidepressant, what does the commercial do after it finishes showing you little bunny foo-foo, jumping through a green, happy people? They tell you, this may create depression, severe depression, and suicidal tendencies, which is the ultimate depression. So, I want everyone to understand you need to figure out what your doctor’s tools are that they’re asking you to take, and they’re wanting you to take it forever, generally in mainstream medicine, right? In the hospitals and everything. They don’t say, hey, your heart has this condition, take this medicine for 3 months, after which time you can get off. Dr. Deb 50:48Yep. David Jernigan 50:49not fixing it, right? So… That, on a timeline, there is a point, if it was truly even fixing anything. That you… it’s done what it should do, and you should get off, even if it’s a natural product. It’s just like. Dr. Deb 51:03Right David Jernigan 51:03It’s done what it should do, and you should get off, but instead. you go through the tree… the correction and out the other side, and that’s where it starts manifesting a lot of the same problems that it had. So, anti-inflammatories, painkillers, imagine the number one side effects are pain inflammation. So, the doctor says, well. If you say, hey, I’m having more pain, what does he do? He ups the dosage. And if he… if that doesn’t work, if you’re still in a lot of pain, which he would be, he changes it to a more powerful thing, right? But it starts the cycle all over again. So when you ask me, it’s like, why are we having so much chronic illness? It’s because of the whole philosophy. is the treatment philosophy of mainstream medicine that despises what you and I do. Because we’re… our philosophy from the start is the biggest thing. It’s like… We’re striving for cure. That dirty four-letter word, cure, we’re not even supposed to use it. And yet, if you look it up in Stedman’s Medical Dictionary, it just means a restoration of health. Remission. Everyone’s like, oh, I’m in remission. I’m like, remission is a drug term. It’s a medical term. Again, look it up in a medical dictionary. It is a pharmaceutical term for a temporary pause Or a reduction of your symptom, but because it’s just… symptom suppression, it will come back. It’s… remission is great, I suppose, in… At the end of, like, where you’ve exhausted everything, because I can’t fix everything, I don’t know about you. Dr. Deb 52:41No, I can’t either, yeah. David Jernigan 52:43you know, on my phone consults, I try to always remind people, as much as I get excited about my technologies gosh, I see so much opportunity to fix you. I always try to go, please understand, I’m gonna tell you what most doctors may not tell you on a phone consultation. I can’t fix everything. Dr. Deb 53:03Yeah. David Jernigan 53:03For all of my tricks, I can’t fix everything. Not tricks, but you know, all my technologies, and all my inventions. Phages, too. They are a tool. You know, antibiotics. I think I wrote a blog one time, it should be on my website somewhere, that says, Antibiotics do not… fix… neurological disease, or… I don’t know, something like that. You know, you’re using the wrong tool. I mean, it does what it does. Dr. Deb 53:32Yeah, you’re using a hammer to do what a screwdriver needs to. David Jernigan 53:35Yeah, you know, it’s like it’s… And yet, you can probably tell her… that you’ve had patients, too, that they go, Dr. Jernigan. My throat was so sore, and as soon as I swallowed that antibiotic. I felt better, and I’m, like, going… How long did it take? Oh, it was immediate! I was like, dude, the gel cap didn’t even have time to dissolve, I mean… Dr. Deb 53:58SIBO. David Jernigan 54:00But, it’s not going to repair the tissues that were all raw. kind of stuff. So, I mean, that ulceration of your throat that’s happening, the inflammation, there’s no anti-inflammatory effect of these things. So, I digress a little bit, but phages, too… I wrote an article that’s on the website, that’s setting healthy expectations for phages, because they want… we can see some amazing things happen, things that in my 30 years, I wish I had all my career to do over again, now having this tool. It’s just that much fun. I… when doctors around the country now are starting to use our inducent formulas, there’s, 13 of them now, formulas. For different broad-spectrum illness presentations. I tell them all the same thing, I was like, you are gonna have so much fun. Dr. Deb 54:53That’s exciting. Women. David Jernigan 54:54Winning is fun, you know? I was like. You know, mainstream medicine may never accept this, I don’t know. I feel a real huge burden, though, to do my best to follow a, very scientific methodology. I’ve published as much as I can publish at this time by myself. I never took money from the… the sources that are out there, because what do they do? They always come… money comes with strings. Dr. Deb 55:22Yes, it does. David Jernigan 55:23I don’t trust… I don’t trust… I mean, if you listen to the, roundtable that Our Secretary Robert F. Kennedy Jr. Dr. Deb 55:35Yeah. David Jernigan 55:36On Lyme disease last week the first couple of speakers were, like, pretty legit. I mean, all of them were legit, but I mean, they were, like, senators and congressmen or something like that, I think. And then you have… RFK Jr. himself, who’s legit. Yeah they were fessing up to the fact that, yes, they were suppressing anything to do with Lyme. Dr. Deb 56:00Yeah. David Jernigan 56:00Our… our highest levels of, marbled halls and pillars and… of medicine were doing everything the way I thought they were. They were suppressing me. I was like, how can you ignore the best formulas ever, and still, I think Borreligen, and now, induced native phage therapy are still, I believe, I don’t… I’ve never seen it, I could be wrong. The only natural things that have been documented in a medical methodology. Dr. Deb 56:34Hmm in the natural realm. I mean, all the herbs that we talk about. David Jernigan 56:39You know, there’s one that was really famous for a while, and it said, we gave… so many patients. This product, and other nutritional supplements. And at the end, X number of them were… dramatically better. That’s not research. Dr. Deb 56:57Right. That’s observation. David Jernigan 56:59The trick there was we gave this one thing, and then we gave high-dose proteolytic enzymes, we gave high dose this, we gave high dose that, but at the end of the study, we’re going to point back at the thing we’re trying to sell you as being what did it. Dr. Deb 57:12Which is what we do in all research, pretty much. David Jernigan 57:15Well… Dr. Deb 57:16tried to… David Jernigan 57:17Good guys, I hope. Dr. Deb 57:18Do the way we want, right? In… in conventional… David Jernigan 57:22Yeah. Dr. Deb 57:22Fantastic David Jernigan 57:23Very often, yeah, in conventional medicine, definitely. Yeah. And, it’s kind of scary, isn’t it, how many pharmaceuticals are slamming us with, because they’re… Dr. Deb 57:33Okay. David Jernigan 57:34There’s a new one on TV every day, and there’s. Dr. Deb 57:36Every day, yes. David Jernigan 57:37It’s like, who comes up with these names? They’re just horrible. Dr. Deb 57:40Yeah, you can’t pronounce them. David Jernigan 57:41I want to be a marketing company and come up with some Zimbabwehika, or something that actually they go with, and I’m like, I just made a million bucks coming up with it. I’ll be glad when that’s not on the TV anymore, which… Oh, me too. Me too. Dr. Deb 57:54Dr. Jaredgen, this was really wonderful. What do you want to leave our listeners with? David Jernigan 58:00Well, you know, everyone’s calling for a new treatment. Dr. Deb 58:05Yeah. You bet. David Jernigan 58:08I have done everything I can do to get it out there, scientifically, in peer review, so that if you want to look up my name. Dr. Deb 58:16I published an open access journal so that you didn’t have to buy the articles. Like, PubMed, you have to be a member. If you want to look at a lot of the research, you have to buy the articles. David Jernigan 58:26I’ve done everything open access so that people had access to the information. I honestly created induced native phage therapy to fix my own wife. I mean, I… I was… I used to think I could actually fix almost anything. Gave me enough time. And, I could not fix her. You know, the first 10 years, she was bedridden. Dr. Deb 58:49Wow. David Jernigan 58:50People go, oh, it’s easy for you, Dr. Jernigan, you’re a doctor. Dr. Deb 58:54Oh yeah, right? Yeah. David Jernigan 58:56Oh my gosh, how many tears have been shed, and how much heartache, and how much of this and that. I mean, 90% of our marriage, she was in, bed, just missing Christmas. All the horror stories you hear in the Lime world, that was her, and I could not get her completely well. And, she’s a very discerning woman. I say that in all my podcasts, because it’s. Dr. Deb 59:19Just… David Jernigan 59:16Amazing. It’s like, every husband, I think, should want a wife that’s… Always, right? Not that you surrender your own opinion, but it’s like, it’s… it was literally, I don’t know what, 6 months before the ILADS conference in Boston in 2029… in 2019 that She said, are you going to the ILADS conference this year? And I’m like, I’ve been going for, like, 15, 20 years, however long it’s been going on, and I was like, I’m not gonna go to this one. And, 3 days before the conference, she says, I think you should go. And I go, okay. Like I say, she’s generally right. And that… I bought a Scientific American magazine at the newsstand in the Nashville airport. Started reading a story about phages in that that copped that edition of the Scientific American, and It was a good article, but it wasn’t super meaty, you know. very deep on those, but I just was stimulated. Something about being at elevation. Dr. Deb 1:00:02Yeah. Your own mountains, I don’t know, I get all inspired. David Jernigan 1:00:25And I wrote in the margins and highlighted this and that until it was, like, ultimately, I spent the entire conference hammering this out. And it worked. And it’s been working, it’s just amazing. It’s… We’re over 200 different infections that we’ve… we’ve clinically or laboratory-wise documented. There’s a new test for my GenX called the CEPCR Lyme Panel. like, culture. 64 different types of infections, and I believe right now the latest count is something like 10 for 10 were completely negative. Dr. Deb 1:01:03Wow. David Jernigan 1:01:03These chronically infected people. And so, that hadn’t been published anywhere. So, in my published article, remember I was talking about that 20 out of the 26 were tested as negative for the infection? That doesn’t mean they’re cured, okay? Remember, they’re chronically damaged. That’s how we need to look at it. Dr. Deb 1:01:23funny David Jernigan 1:01:24damaged. You’re not just chronically infected. And, but with 30-day treatment.24 out of the 26 were tested as negative. Dr. Deb Muth 1:01:34That’s amazing. David Jernigan 1:01:35So 92% of the people were negative.Okay? The chances of that happening, when you run it through statistical analysis.The chances… when you compare the results to the sensitivity percentages, you know, the 100% specificity and 92% sensitivity of the…Of the lab testIt’s a 4.5 nonillion to 1 chance that it was a fluke. Isn’t that amazing? Now, nearly… I’m not even sure how many zeros that is, but it’s a lot. Dr. Deb Muth 1:02:08That’s is awesome. David Jernigan 1:02:09Like, if I just said, well, it’s a one in a million chance it was a fluke.Okay.So, lab tests don’t lie. You’re not done, necessarily, just because you got rid of the infections. Now that formula for Lyme has grown to be 90-plusmicrobes targeted in the one formula. So, we figured out we can actually target individually, but collectively, almost like an antibiotic that’s laser-guided to only go after the bad guys that we targeted.So, all the Borrelia types are targeted, all the Babesias, for,the Bartonellas, the anaplasmosis, you name it, mycoplasma types are all targeted in that one formula, because I said.Took my collective 30 years of experience and 15,000 patients.that I would typically see as co-infections and put them into that one formula, so…When we get these tests coming back that are testing for 64, it’s because of that.So, there’s a lot of coolnesses that I could actually keep going and going. Dr. Deb Muth 1:03:15That’s exciting. David Jernigan 1:03:15I love this topic, but I thank you for letting me come on. Dr. Deb Muth 1:03:18Thank you for joining us. How can people find you? David Jernigan 1:03:22Two ways. There’s the Phagen Corp company that is now manufacturing my formulas.That is P-H-A-G-E-N-C-O-R-P dot com. Practitioners can go there, and there’s a practitioner side of the website that’s very beefy with science, and… and all the formulas that were used, what’s inside of all the formulas, meaning what microbes are targeted by each one. Like, there’s a GI formula, there’s a UTI formula, there’s a SIRS formula, there’s a Lyme formula, there’s a central nervous system type infection formula, there’s… And we can keep going, you know, SIBO, SIFO formula, mold formula… I mean, we’ve discovered so many things that I could just keep going for hours, and… Dr. Deb Muth 1:04:05Yeah. David Jernigan 1:04:06About the discoveries, from where it started in its humble beginnings, To now, so… There’s another way, if you wanted to see our clinic website, is Biologics, with an X, so B-I-O-L-O-G-I-X, Center, C-E-N-T-E-R dot com. And, if somebody thinks they want to be a patient and experience this at our clinic, typically we don’t take just Easy stuff. All we see is chronic.Chronic cases from all over the world. Something like 96% of our patients come from other states and countries. And typically, I’ve been close to 90% for my whole career.About 30-something percent come from other countries in that, so… we’ve gotten really good and learned a lot in having to deal with what nobody else knows what to do with. But if you do want to do that, you can contact us. And, if you… If you don’t get the answers from my patient care staff, then I do free consultations. With the people that are thinking about, whether we can help them or not. Dr. Deb Muth 1:05:13Well, that’s excellent. For those of you who are driving or don’t have any way of writing things down, don’t worry about it, we’ve got you. We will have all of his contact information in our show notes, so you will be able to reach out to him. Thank you again for joining me. This has been an amazing conversation. David Jernigan 1:05:30Thank you, I appreciate you having me on. It was a lot of fun. The post Episode 252 – Induced Native Phage Therapy (INPT) & advanced natural therapies first appeared on Let's Talk Wellness Now.

In this edition of Moneycontrol Editor's Picks we analyse the India-New Zealand FTA - from what Chinese products the deal can replace to the opposition from a section of NZ administrators, we tell you why the FTA matters more than its critics admit. Also inside: Union budget incentive for small aircraft manufacture, why RBI is watchful of the low inflation scenario, how the top 4 brokers remain optimistic despite losing a significant investor base, why the broader market did not respond to GST and interest rate cuts, how the nightmare for H1B visa holders continues and why 2026 will be the year of weightloss drugs in India. Tune in.

0:30 - TP USA AmericaFest 38:05 - Chicago City Council passes budget 57:33 - The Gary Bears?!? 01:16:15 - Steven Bucci, visiting fellow at The Heritage Foundation’s Allison Center for Foreign Policy Studies, weighs in on Venezuela, the Russia–Ukraine talks — and even Saturday night’s Bears game. 01:33:33 - Retired FBI counterterrorism and counterintelligence agent Eric O’Neill on the Brown University shooter manhunt — and insights from his new book Spies, Lies, and Cybercrime. 01:51:26 - FTA rejects CTA Safety Plan 02:07:46 - The Gary Bears?!? - Part IISee omnystudio.com/listener for privacy information.

On Episode 758 of The Core Report, financial journalist Govindraj Ethiraj talks to Sandip Agarwal, Fund manager at Sowilo Investment Managers LLP as well as Parizad Sirwalla, Partner and National Head – Tax, Global Mobility Services, KPMG in India.SHOW NOTES(00:00) Stories of the Day(01:09) The markets are up as FIIs step in for some late or early buying(11:28) Why an appreciating Thai Baht should concern us all(13:16) The surprise market that beat Wall Street in 2025(14:10) Geopolitical tensions drive up oil and gold prices(17:09) India-New Zealand sign third FTA for India this yearRegister for India Energy Week 2026https://www.indiaenergyweek.com/forms/register-as-a-delegateFor more of our coverage check out ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠thecore.in⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Subscribe to our Newsletter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow us on:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Linkedin⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠

अजमेर दरगाह में 814वें उर्स पर पीएम मोदी की ओर से चादर पेश की गई, मोदी ने न्यूज़ीलैंड के पीएम से FTA पर बातचीत की, यूपी में कोडीन कफ सिरप विवाद पर सीएम योगी का सपा पर हमला, नीतीश कुमार ने दिल्ली में पीएम और अमित शाह से मुलाकात की, कांग्रेस नेता गोगोई ने पीएम की असम यात्रा की आलोचना की, एयर इंडिया की फ्लाइट की इमरजेंसी लैंडिंग, सुप्रीम कोर्ट ने अजमेर चादर याचिका पर सुनवाई टाली और उत्तराखंड में अवैध वन भूमि कब्जे पर टिप्पणी की, LUCKNOW KGMU में धर्मांतरण जांच शुरू और शेख हसीना ने बांग्लादेश की भारत विरोधी भावना की आलोचना की. सिर्फ 5 मिनट में सुनिए दोपहर 1 बजे तक की बड़ी खबरें.

1부 [JB TIMES] 민주 ‘정보통신망법' 위헌 논란 일자 또 수정 6cm 눈에 서울 마비, 원인은 ‘제설지침 삭제' '김건희 봐주기' 이창수, 특검 소환 불응.."일정상 어려워“ ‘통일교 의혹' 전재수, 여론조사서 박형준 앞서..의미는? 한미FTA 공동위 연기..”디지털 규제에 미국 불만” 5년 만에 학원비 줄었다..감소폭은 소득구간별 차이 커 - 더 막내작가

In this edition of Moneycontrol Editor's Picks we tell you how SEBI rules lower the fees paid by mutual fund houses, why India kept key sectors out of its FTA with Oman, if TCS will be able to turn its stock market fortunes, and why G Ram G is more than just a name change. Besides, find the latest from markets to ambitious government projects - tune in.

Indian conglomerates shine in an uncertain year, Moneycontrol ascertains brokerages' predictions, Delhi-Muscat set to sign FTA, Rupee's biggest single-day gain against the US dollar, Saregama banks on Bhansali productions and the IPL's income inequality - find reports that track all this and more in the latest edition of Moneycontrol Editor's Picks.

Labour’s Trade Spokesman joins us for our final argument of 2025! Plus, we discuss SOPI, an FTA with India and O'Connor's Ag Person of the Year.See omnystudio.com/listener for privacy information.

We ask the NZ First leader and Minister of Foreign Affairs about “survive to ’25” and “the fix for ’26”. We also discuss the latest polls, RMA reforms, an FTA with India, and Stuart Nash. Plus, how many more elections does the 80-year-old have left in him?See omnystudio.com/listener for privacy information.

In this week's episode of Transit Unplugged, Paul Comfort sits down with Jay Fox, Executive Director of the Utah Transit Authority (UTA) — one of the fastest-growing, highest-performing transit agencies in the United States and APTA's 2025 Transit System of the Year.Jay brings a remarkable background across FAA, FTA, Amtrak, and SEPTA — and now leads the agency serving one of the most dynamic, youthful, and transit-hungry regions in America.Together, Paul and Jay dive into:Preparing for the 2034 Winter OlympicsJay shares why UTA told the IOC: “We're ready now.”UTA's rail, BRT corridors, FrontRunner upgrades, and multimodal network already form a complete backbone for Olympic mobility — with more enhancements on the way. FrontRunner 2X: The Generational Rail ProjectUTA is pushing to move from 25% to 50% double-tracking, enabling:-15-minute peak service -A new infill station -A new maintenance facility -Pathways to Sunday service…all while ridership continues to soar. A Multimodal System Built for GrowthUTA operates:-131 miles of rail (commuter, light rail, streetcar) -Three BRT lines (including OGX, electric and wildly successful) -Extensive bus, microtransit, vanpool, and paratransit services -A booming Ski Bus network that keeps the canyons moving Transit ROI: The Utah ModelJay breaks down the hard numbers on economic impact:-$9.6B in economic output generated -$377M in tax revenue returned -79,000 jobs supported -Ever $1 invested netted a $5.11 returned to the regional economyAll from an operating budget of roughly $480M. Why UTA's Riders Are Getting YoungerJay explains how university partnerships, free-fare programs, and campus connectivity are transforming ridership patterns — and why student riders today become lifelong riders tomorrow.Global CollaborationUTA is working with LA Metro, LA28, and Milan/Cortina teams to prepare for back-to-back Olympic cycles (2026, 2028, 2034), exchanging insights on operations, vehicle staging, and major-event transport logistics.This is one of the most wide-ranging, energizing episodes we've recorded — and a perfect companion to our upcoming Transit Unplugged TV episode filmed on location in Utah.Host: Paul ComfortExecutive Producer: Julie GatesProducer: Paul ComfortEditor: Patrick EmileAssociate Producer: Cyndi RaskinBrand design: Tina OlagundoyeSocial Media: Tatyana MechkarovaIf you have a question or comment, email us at info@transitunplugged.com.Follow us on social media:https://www.linkedin.com/company/transit-unplugged/https://x.com/transitunplughttps://www.threads.net/@transitunpluggedhttps://www.instagram.com/transitunplugged/Sign up for the Transit Unplugged Newsletter: https://transitunplugged.com/subscribe-to-the-transit-unplugged-newsletter/Disclaimer: The views and opinions expressed in this program are those of the guests, and do not necessarily reflect the views or positions of Modaxo Inc., its affiliates or subsidiaries, or any entities they represent (“Modaxo”). This production belongs to Modaxo, and may contain information that may be subject to trademark, copyright, or other intellectual property rights and restrictions. This production provides general information, and should not be relied on as legal advice or opinion. Modaxo specifically disclaims all warranties, express or implied, and will not be liable for any losses, claims, or damages arising from the use of this presentation, from any material contained in it, or from any action or decision taken in response to

The Prime Minister ponders an FTA with India, the RMA reforms, the latest 1News poll, and whether lamb beats ham for Christmas in the Luxon household.See omnystudio.com/listener for privacy information.

[깊이 있는 경제뉴스] 1) 추가 공개된 미중 합의.. 韓 조선·자동차 안도 2) 한중 70조 통화 스와프.. FTA 2단계도 논의 3) 워런 버핏, 현금 보유량 또 늘렸다 4) ‘호실적' 국민연금, 올해만 200조 벌었다 - 조미현 한국경제신문 기자 - 정지서 연합인포맥스 기자 [친절한 경제] 우리나라 가계 자산, 부동산 비중 70% 넘는 이유는? - 청취자 문종훈 씨

관세, 일본보다 잘했지만 FTA 상실은 아쉽다美, 이중 메시지…서명 전까지 끝난 게 아니다미중정상회담, 휴전보다는 충격 완화의 단계트럼프, 핵실험 지시…중국 아닌 러시아 압박핵잠, 文 때도 검토했지만실현까지는 시간 필요 ■ 방송 : CBS 라디오 FM 98.1 (07:10~09:00)■ 진행 : 김현정 앵커■ 대담 : 최종건 (前 외교부 차관)See omnystudio.com/listener for privacy information.

[깊이 있는 경제뉴스] 1) 코스피 4000 돌파… ‘5000 시대‘ 성패 가르는 핵심 요인은? 2) 韓-말레이 FTA 체결… 車·철강 업계에 수출길 열린다 3) 이찬진 “새마을금고 문제 많아… 3분의 1은 통폐합해야“ 4) 트럼프, 남미 정치에 적극 개입… 두 대통령 웃고 울었다 - 김치형 경제뉴스 큐레이터 - 정지서 연합인포맥스 기자 - 조미현 한국경제신문 기자